Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05481892 · ClinicalTrials.gov registry record · NA
Remote Monitoring for Equity in Advancing Control of Hypertension
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 540
- Enrollment target
NCT05481892 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 540 participants.
The verdict
NCT05481892, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 540 participants
- Enrollment target
Study Summary
The goal of this study is to support patients with hypertension self-management using both home blood pressure monitors and digital messaging programs. The investigators will first engage patients with technology training to use home monitors, online portal websites to view their medical record information online, and texting and mobile phone applications. Then investigators will assess the effectiveness of home blood pressure monitors and enhanced patient-clinician digital communication on blood pressure control during a 12-month intervention.
Interventions
- DEVICE Cellular Home blood pressure (BP) monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 540 participants |
| Start Date | 2023-04-20 |
| Est. Completion | 2026-04-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05481892
The ClinicalTrials.gov registry entry for NCT05481892 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 540 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cellular Home blood pressure (BP) monitoring is the first listed.
NCT05481892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05481892 about?
NCT05481892 is a clinical study titled "Remote Monitoring for Equity in Advancing Control of Hypertension". The goal of this study is to support patients with hypertension self-management using both home blood pressure monitors and digital messaging programs. The investigators will first engage patients with technology training to use home monitors, online portal websites to view their medical record info...
What is the current status of trial NCT05481892?
This trial is currently completed. It is a NA study. The enrollment target is 540 participants. The study started on 2023-04-20. Estimated completion is 2026-04-16.
What interventions are being tested in trial NCT05481892?
The interventions under investigation include: Cellular Home blood pressure (BP) monitoring (DEVICE).
Who is sponsoring clinical trial NCT05481892?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.